Status:
COMPLETED
12-Week Study on the Efficacy of Two Serums in Improving Skin Aging and Tone
Lead Sponsor:
ChinaNorm
Conditions:
Facial Skin Aging and Dullness
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
This study aims to evaluate the anti-aging and skin tone improvement effects of two facial serums over a 12-week period. It was conducted at a single research center with a 2-week washout period follo...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Chinese female aged 18-45 years (evenly split among Early aging \[18-29 years\] and Mature aging \[30-45 years\]).
- All skin types (dry, normal, oily, or mixed).
- Currently experiencing lack of radiance, roughness, dullness, and fine lines or wrinkles on facial skin as self-claimed.
- Early aging group (18-29 years): Must present with corresponding severity for the attributes evaluated by Dermatologist, including:
- Skin smoothness, radiance, dullness: grade between 2 and 6 (scale 0-9);
- Size of acne marks (PIH): size ≥ 2;
- Small folds on nasolabial zone: grade between 1 and 3 (Skin Aging Atlas, 0-6 scale, Page 56-57).
- Mature aging group (30-45 years): Must present with corresponding severity for the attributes evaluated by Dermatologist, including:
- Skin smoothness, radiance, dullness: grade between 4 and 6 (scale 0-9);
- Small folds on nasolabial zone: grade between 1 and 4 (Skin Aging Atlas, 0-6 scale, Page 56-57);
- Forehead wrinkles: grade ≥ 2 (Skin Aging Atlas, 0-8 scale, Page 32-33);
- Crow's feet wrinkles: grade ≥ 2 (Skin Aging Atlas, 0-6 scale, Page 40-41).
- Regular user of serum and sunscreen products.
- Did not participate in any clinical test or cosmetic product test on skin within the last 3 months.
- No exclusion by dermatologist due to other medical or dermatological reasons.
- In general good health at the time of the study.
- Willing and able to participate as evidenced by signing of informed consent and photo release form.
- Must be willing to comply with all study protocol requirements (including using only the skincare products provided during the study and not taking topical or oral treatments such as retinol, hormones, or antioxidant health supplements).
Exclusion
Key Trial Info
Start Date :
November 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 22 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT07156071
Start Date
November 18 2023
End Date
March 22 2024
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai China-norm Quality Technical Service Co., Ltd., Shanghai, Shanghai 200072
Shanghai, China